Home/Filings/4/0001156039-21-000026
4//SEC Filing

Alter Jeffrey D. 4

Accession 0001156039-21-000026

CIK 0001156039other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:33 PM ET

Size

7.2 KB

Accession

0001156039-21-000026

Insider Transaction Report

Form 4
Period: 2021-03-01
Alter Jeffrey D.
EVP, IngenioRx & Anthem Health
Transactions
  • Award

    Common Stock

    2021-03-01+2,6495,395 total
  • Award

    Employee Stock Option (Right to Buy)

    2021-03-01+10,87610,876 total
    Exercise: $311.48Exp: 2031-03-01Common Stock (10,876 underlying)
Footnotes (2)
  • [F1]Represents restricted share units. Restrictions lapse as follows: 883 shares each on 3/1/2022, 3/1/2023 and 3/1/2024.
  • [F2]The option represents a right to purchase a total of 10,876 shares, and is exercisable in three annual installments, with two installments of 3,625 shares each and one installment of 3,626 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.

Issuer

Anthem, Inc.

CIK 0001156039

Entity typeother

Related Parties

1
  • filerCIK 0001813868

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:33 PM ET
Size
7.2 KB